Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole combined with gonadotropin in infertile women with diminished ovarian reserve undergoing IVF
IRCT20140224016705N9Phase 4Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Mar 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of letrozole and follicle-stimulating hormone in female infertility and Diminished Ovarian Reserve (DOR), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Number of oocytes achieved, Mean endometrial thickening and 1 more. Started Mar 2017; status: completed.
02
Drugs
letrozolefollicle-stimulating hormone
03
Conditions
female infertilityDiminished Ovarian Reserve (DOR)
Beyond the preview
Go deeper on IRCT20140224016705N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140224016705N9.